BioSpace News Archive

Vaccitech’s VTP-300 induced sustained reductions of surface antigen in patients with chronic hepatitis B both as a monotherapy and in combination with a single low dose of anti-PD-1

Vaccitech plc announced an update to the interim analysis of safety and efficacy data from the HBV002 study, which is being presented as a poster at the 2022 EASL International Liver CongressTM by Professor Ellie Barnes, Professor of Hepatology and Experimental Medicine at the University of Oxford.

June 22, 2022
·
9 min read
Policy

Takeda Announces Creation of One Cambridge Campus in Kendall Square to Drive Innovation Efforts

Takeda announced that it has signed a 15-year lease with BioMed Realty for approximately 600,000 square feet of research and development and office space to be built at 585 Third Street in Kendall Square.

June 22, 2022
·
8 min read
Deals

ProMIS Neurosciences Announces Filing of Form 10 Registration Statement and Nasdaq Listing Application

ProMIS Neurosciences Inc. today announced that it has filed a registration statement on Form 10 (the “Registration Statement”) with the United States Securities and Exchange Commission (“SEC”).

June 22, 2022
·
5 min read
Deals

ProMIS Neurosciences Announces Authorization of Series 1 Preferred Shares

ProMIS Neurosciences Inc. today announced that it has amended its articles to authorize the issuance of 70,000,000 Series 1 Preferred Shares.

June 22, 2022
·
3 min read
Biotech Bay

Alladapt Announces Completion of Oversubscribed $119 Million Institutional Financing

Financing from new and existing investors will support continued development of a novel treatment for food allergy.

June 22, 2022
·
6 min read
Lone Star Bio

Castle Adds to Evidence Supporting Its Skin Cancer Test Portfolio through Multiple Data Presentations at the SDPA Annual Summer Dermatology Conference 2022

New data from pooled analysis shows DecisionDx ® -Melanoma can identify patients at a high risk of melanoma recurrence within a patient population deemed low risk ( T1, ≤1mm) by traditional staging systems.

June 22, 2022
·
14 min read
NuGen M.D. Launches PetJet(TM) Providing Needle-Free Injections for Domesticated Pets

NuGen Medical Devices Inc. is pleased to announce that it will be launching a needle-free injection device specifically designed for domesticated household pets.

June 22, 2022
·
4 min read
Genetown

Moderna Announces Bivalent Booster mRNA-1273.214 Demonstrates Potent Neutralizing Antibody Response Against Omicron Subvariants BA.4 And BA.5

mRNA-1273.214 Exhibited a Greater Than 5-Fold Boost in Neutralizing Antibodies Against BA.4 and BA.5 Subvariants in Phase 2/3 Study.

June 22, 2022
·
5 min read
Drug Development

BridgeBio Pharma Announces Early Positive Data for BBP-812, its Investigational AAV9 Gene Therapy for Canavan Disease

These results are the first reported demonstration of rapid and robust treatment changes in key disease markers associated with the severity of disease.

June 22, 2022
·
9 min read
BioCapital

OpGen Announces 1,000th Patient Sample Enrolled in Clinical Trial for Unyvero Urinary Tract Infection Panel

Prospective multicenter trial for the Unyvero UTI panel recruited its 1,000th prospective patient sample.

June 22, 2022
·
5 min read